The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often viewed as outdated and hindering progress, https://umarimnx668772.wikilinksnews.com/6631070/marijuana_rescheduling_a_development_catalyst